Syncona : OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board -September 27, 2023 at 04:52 am EDT

OMass Therapeutics , a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the...

Related Keywords

United States ,United Kingdom ,American ,British ,Dame Carol Robinson ,Mark Namchuk ,Rosamond Deegan ,Ali Jazayeri ,Twitter ,Linkedin ,Molecular Pharmacology At Harvard Medical School ,American Research ,Oxford Science Enterprises ,Vertex Pharmaceuticals ,Clinical Development At Alkermes ,Scientific Advisory Board ,Executive Director ,Therapeutics Translation ,Biological Chemistry ,Molecular Pharmacology ,Harvard Medical School ,Senior Vice President ,Non Clinical Development ,North American ,Professor Dame Carol Robinson ,Chief Scientific Officer ,Chief Executive Officer ,Stella Lempidaki ,Kumail Waljee ,Northpond Ventures ,Sanofi Ventures ,British Patient ,Markets ,